Results from a meta-analysis involving data from six phase III studies show that patients taking the chemotherapy pill Xeloda actually live longer than those receiving intravenous (IV) chemotherapy 5-FU/FA*.

Read the rest of this entry »

NEW YORK (Reuters Health) Jun 23 - Implementation of breast cancer outreach initiatives in Atlanta, Georgia, doubled the proportion of stage 0 tumors diagnosed in African American women since 2001, with a nearly reciprocal drop in the proportion of stage 4 diagnoses, investigators report in the August 1st issue of Cancer.

Read the rest of this entry »

Chuck Grassley is at it again. The senator from Iowa is looking into a Stanford psychiatry professor’s multimillion-dollar stake in a drug company called Corcept Therapeutics.Alan Schatzberg, who heads Stanford’s psych department, followed the university’s rules and reported having a stake of more than $100,000 in the company. According to Grassley, Schatzberg’s total stake in the company may be worth some $6 million.

Read the rest of this entry »

Patients who received the chemotherapy drug gemcitabine after surgery for pancreatic cancer lived 2 months longer than patients who had surgery alone, according to the final results of a large, randomized clinical trial presented at the ASCO annual meeting last week. Read the rest of this entry »